Transcriptomics analysis revealed that genes involved in hepatic de novo cholesterol synthesis were down-regulated in fed HSL-null mice that had been on high-fat diet (HFD) for 6 months. This finding prompted a further analysis of cholesterol metabolism in HSL-null mice, which was performed in fed and 16-h fasted mice on a normal chow diet (ND) or a HFD regimen. Plasma cholesterol was elevated in HSL-null mice, in all tested conditions, as a result of cholesterol enrichment of HDL and VLDL. Hepatic esterified cholesterol content and ATP binding cassette transporter A1 (ABCA1) mRNA and protein levels were increased in HSL-null mice regardless of the dietary regimen. Unsaturated fatty acid composition of hepatic triglycerides was modified in fasted HSL-null mice on ND and HFD. The increased ABCA1 expression had no major effect on cholesterol efflux from HSL-null mouse hepatocytes. Taken together, the results of this study suggest that HSL plays a critical role in the hydrolysis of cytosolic cholesteryl esters and that increased levels of hepatic cholesteryl esters, due to lack of action of HSL in the liver, is the main mechanism underlying the imbalance in cholesterol metabolism in HSL-null mice.
INTRODUCTION
Hormone-sensitive lipase (HSL) is best known as the enzyme hydrolyzing acylglycerols stored in adipose tissue (49). In addition to acylglycerols, it hydrolyzes several other lipids, including cholesteryl esters, retinyl esters and lipoidal esters, and also water-soluble esters (25, 47) . HSL is widely expressed and besides adipose tissue it is present in steroidogenic tissues, liver, skeletal muscle, intestinal mucosa, macrophages and pancreatic β-cells (49). Its role in non-adipose tissues is not completely understood, but the phenotype revealed by the characterization of several independently generated HSL-null mouse lines during the recent years, suggests that HSL has several functions in addition to its role in adipocyte lipolysis (14, 22, 26, 42) . Thus, the picture of HSL being a multifunctional enzyme involved in lipid metabolism and lipid signalling is emerging.
One feature shared among all characterized HSL-null models is lack of obesity (14, 22, 26, 42) . HSL-null mice have in fact been shown to be resistant to diet-induced obesity (17) .
Despite the lack of obesity an inflammatory response characterized by macrophage infiltration and increased necrotic-like cell death has been observed in white adipose tissue of HSL-null mice (7, 16) . Adipose tissue inflammation is a condition frequently observed in the obese state and a possible trigger of obesity-associated insulin resistance and its complications, such as non-alcoholic fatty liver disease. The HSL-null mouse line established in our laboratory is indeed characterized by insulin resistance observed at the level of the liver as well as skeletal muscle and adipose tissue (22). However, conflicting data have been reported for other HSL-null mouse strains, showing increased hepatic insulin sensitivity (27, 48) .
Besides the lack of obesity, other features consistently observed in the different HSLnull mouse lines are decreased levels of plasma non-esterified fatty acids (NEFA) and increased levels of plasma cholesterol (15, 42, 48) . Decreased levels of plasma NEFA result from impairment of adipocyte lipolysis and are, as expected, most pronounced in the fasted state. In the model established by Haemmerle et al., the decreased levels of plasma NEFA have been shown to result in decreased hepatic synthesis of VLDL (15) , which in turn presumably is the main cause of the low plasma triglyceride levels observed in HSL-null mice (11, 15, 17, 48) . The elevation of plasma cholesterol, shown to be accompanied by increased HDL-cholesterol (15) is intriguing. Noteworthy, neutral cholesterol ester hydrolase activity is abolished, or at least dramatically reduced, in all HSL-expressing tissues, including Cholesterol metabolism in HSL-null mice 4 the liver, with macrophages being an exception showing only slightly reduced cholesterol ester hyhdrolase activity (9, 13, 22, 26) . Lipase activity, on the other hand, is intact or much less reduced in non-adipose tissues of HSL-null mice (9, 13, 22, 26) . This suggests that HSL may act as a cholesterol ester hydrolase in many tissues whereas its function as a lipase may be confined to adipose tissue.
The decreased hepatic insulin sensitivity observed in our strain of HSL-null mice, together with the intriguing elevation of plasma cholesterol, prompted us to perform a transcriptomics analysis of the liver of HSL-null mice in order to gain insight into the mechanisms underlying these features of the HSL-null mouse model and to learn more about the role of HSL in the liver. The most striking result upon this analysis was the downregulation of eight genes encoding enzymes catalyzing successive steps in de novo synthesis of cholesterol. Based on these findings the major aim of the present study was to perform a detailed analysis of cholesterol homeostasis in HSL-null mice. The results obtained support a role for HSL in the cytosolic hydrolysis of hepatic cholesteryl esters and furthermore suggest that HSL, via this role, is important for the maintenance of cholesterol homeostasis.
EXPERIMENTAL PROCEDURES
Animals. HSL-null mice were generated by targeted homologous recombination of the HSL gene in 129SV-derived embryonic stem cells as described elsewhere (13) . HSL-null and wildtype control mice were littermates and had a mixed genetic background from the inbred strains C57BL/6J and SV129. The animals were maintained in a temperature-controlled room (22°C) on a 12-h light-dark cycle. Female mice were employed throughout this study. Mice, 8-10 weeks of age, were fed ad libitum a normal chow diet (ND) containing 4.8% fat and 0.005% cholesterol or a high-fat diet (HFD) containing 35.9% fat and 0.03% cholesterol (Research Diets, New Brunswick, NJ; products no D12310 and D12309, respectively), as indicated in the figure legends, before the in vitro analyses were performed. Mice were killed by cervical dislocation and tissues were rapidly dissected, snap frozen and stored in liquid nitrogen or at -80°C until analysis. The studies were approved by the local Animal Ethics Committee at Lund University.
Microarray Analysis and Gene Ontology Analysis. Equal amounts of liver samples from
four to six HSL-null or wildtype fed mice were pooled and RNA was extracted according to Chomczynski and Sacchi (6) . Total RNA was purified using RNeasy Kit (Qiagen).
Biotinylated c-RNA was prepared following the protocol from Affymetrix and hybridized to mouse Affymetrix MG-U74A-v2 chips. The chips were washed, scanned and subsequently analyzed with the Affymetrix Genechip MAS V.5.0 software. The chips were standardized by global scaling to a target intensity of 100. In order to identify genes differently expressed, three parameters that are calculated independently were combined: detection call, change call and signal log ratio of base 2 (SLR). To be considered down-or up-regulated, a gene had to be detected in at least one of two groups, the expression level between two groups had to be identified as increased or decreased and finally the SLR had to be ≥ 1 or ≤ -1 respectively, which corresponds to a fold change ≥ 2 or ≤ -2. The total set of data is accessible through the GEO repository as series IDGSE10067.
The 12488 genes and ESTs present on the chip were mapped to 4589 Gene Ontology categories (18) using the web server ACID (31). The genes were ranked in decreasing order of absolute value of logarithmic fold change between HSL-null mice on HFD and wildtype mice on HFD, i.e., the genes with the largest fold changes, up or down, had the lowest ranks.
A Wilcoxon rank sum test was employed for each GO category using the publicly available program Catmap (2) . Catmap outputs, among others, 1) P-values calculated as the probability that a random ordering of the genes produces a lower, or equally low, Wilcoxon rank sum as the ordering investigated, 2) false discovery rates for lists of GO categories, and 3) an ROC area for each category, which is a normalized form of the Wilcoxon rank sum. The ROC area ranges from zero to one; the ROC area is one when the Wilcoxon rank sum attains its minimum and zero when the Wilcoxon rank sum attains its maximum. For large GO categories, the P-value can be very small even for ROC areas far below one (but above 0.5).
Real-Time Quantitative PCR. Total liver RNA was isolated using RNeasy Kit (Qiagen) from fed and 16 hours fasted over-night mice and then 1 µg was treated with DNase I (DNase amplification grade, Invitrogen). The purified RNA was reversely transcribed using random hexamers (Amersham Biosciences) and SuperScriptII reverse transcriptase (Invitrogen Life Technologies). PCR was performed with an ABI 7900 system (Applied Biosystems). The following mouse Taqman primers were used: Gapdh (Mm99999915_g1); ABCA1 (Mm00442646_m1); Abcg1 (Mm00437390_m1), Lrp1 (Mm01160450_g1) and Scd1 (Mm00772290_m1). Additionally, SYBR green primers for the following genes were used:
Hprt1; Rps29; HMG-CoA reductase; Fdps; LDL receptor and SR-BI. Primers were designed using the software Primer Express 1.5 (Applied Biosystems) and the sequences are found in supplemental data. Relative abundance of mRNA was calculated after normalization by geometric averaging of three internal control genes (Gapdh, Hprt1 and Rps29) (40).
Plasma Lipids and Lipoprotein Analysis. Blood samples were drawn by retro-orbital puncture in isofluorane anaesthetized mice using EDTA as an anti-coagulant. Mice were either re-fed (over-night fasting for 12 hours followed by 2 hours of free access to food) or fasted for 16 hours over-night. The plasma concentrations of triglycerides, cholesterol and NEFA were determined using commercially available kits (Thermo Trace; Wako Chemicals).
Samples from pooled plasma (n=12−14) were separated by fast performance liquid chromatography (FPLC) gel filtration (ÄKTA Explorer, GE Healthcare) with a Superose 6 HR 10/30 column. Aliquots of 200 µl were injected onto the column and separated with PBS buffer, pH 7.4, at a flow rate of 0.2 ml/min (28). Triglyceride and cholesterol in the collected fractions were assayed as stated above.
Western Blot Analysis. Liver samples were homogenized in lysis buffer pH 7.0 containing 25 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton and 1X protease inhibitor cocktail (Complete Mini, Roche). Total protein concentration was measured by BCA assay (Pierce) and 50 µg of protein were subjected to SDS-polyacrylamide gel electrophoresis (8 % polyacrylamide). After transfer to PVDF membranes (Invitrogen), blots were incubated with a primary antibody mouse anti-mouse/rat ABCA1 (Neuromics) according to the instructions of the manufacturer. As secondary antibody a horseradish peroxidase-conjugated sheep antimouse IgG was used. Western blot analysis was performed using a chemiluminescence system (Luminol) and detection was made using a CCD-camera (LAS 1000, Fuji). Band intensities were quantified using the ImageJ software (http://rsb.info.nih.gov/ij).
Liver Cholesterol. Total hepatic lipid content was extracted from mice that were either fed or fasted over-night for 16 hours (10). In brief, 50 mg of liver were homogenized in 1 ml of PBS and an aliquot corresponding to 20 mg was transferred to a glass tube containing 2:1 chloroform:methanol (v/v) and incubated over night at 4˚C. After washing twice with water, the organic phase was dried under nitrogen gas. The lipids were then redissolved in chloroform, separated by thin layer chromatography (TLC) in a phase consisting of ether:petroleum ether:acetic acid (15:84:1) and the lipid spots were detected using iodine vapour. Silica gel of samples corresponding to the spots of cholesterol and cholesterol oleate standards were scraped and washed three times in chloroform. The samples were then dried under nitrogen gas and suspended in isopropanol before free and esterified cholesterol were measured using commercial kits (Free Cholesterol, Wako Chemicals and Infinity Cholesterol Liquid Stable Reagent kit, Thermo Electron).
Liver triglycerides. Acylglycerides were extracted from the liver of fed and 16 hours overnight fasted mice and quantified using a kit (Thermo Trace) (3). was performed to test whether the fitted areas differed between the two genotypes. In all tests P < 0.05 was considered to be significant.
RESULTS

Downregulation of genes involved in de novo synthesis of cholesterol in HS-null mice.
Transcriptome analysis of the liver was performed by microarray in fed HSL-null and wildtype mice that had been on a normal diet (ND) or a high fat diet (HFD) for six months.
Genes involved in the biosynthesis of lipids represented the gene ontology category that was the most regulated in fed HSL-null mice on HFD (small P-value and ROC area close to 1) ( Table 1 ). More specifically, twelve probe sets representing eight genes coding for enzymes catalyzing successive steps in de novo synthesis of cholesterol were down-regulated ( Table 2 and Fig. 1 ). This included two probe sets for HMG-CoA reductase mRNA (2.8-fold and 10.6-fold decrease), two probe sets for farnesyl diphosphate synthase mRNA (Fdps) (3.2-fold and 3-fold decrease) and three probe sets for NADP-dependent steroid dehydrogenase like mRNA (Nsdhl) (3.2-fold, 3-fold and 2-fold decrease). In order to validate some of the results obtained in the microarray analysis, real-time quantitative PCR (RT-PCR) was performed.
For this analysis fed as well as 16 hours fasted mice were used. The decrease in mRNA levels for HMG-CoA reductase and Fdps in fed HSL-null mice on HFD was confirmed by RT-PCR (P = 0.09 and P < 0.05, respectively) ( Fig. 2A and B ). In addition, a reduction in mRNA levels was observed in fasted HSL null mice on HFD for both HMG-CoA reductase (P <0.05) and Fdps (P = 0.06). Fdps mRNA levels were reduced also in fasted HSL-null mice on ND (P < 0.05) (Fig. 2B ).
HSL-null mice have a perturbed plasma lipid profile. Following the observation that several genes involved in de novo cholesterol synthesis were down-regulated in HSL null mice, the plasma levels of cholesterol, triglycerides and NEFA were measured in re-fed (over-night fasting for 12 hours followed by free access to food for 2 hours) and 16 hours fasted mice.
The re-fed scheme was used in order to synchronize the mice and to ensure that a true postprandial state was analyzed. Fasting for 16 hours represents a nutritional state that should maximize the impact of HSL deficiency. Plasma cholesterol was elevated in HSL-null mice in all tested conditions: ND and HFD; re-fed and fasted (P < 0.05, except for fasted mice on HFD where statistical significance was not attained) ( Table 3 ). The increase was on average 25 %. Plasma triglycerides were elevated by on average 50 % in re-fed HSL-null mice (P < 0.05, except for re-fed mice on HFD where statistical significance was not attained), whereas plasma triglycerides levels in the fasted state were decreased by on average 55 % regardless of dietary regimen (P < 0.001) (Table 3) . Similarly, plasma NEFA were increased in re-fed and decreased in fasted HSL-null mice, in both dietary conditions, by on average 40 and 30 %, respectively (P < 0.05 or less) ( Table 3) .
HSL-null mice have cholesterol-enriched lipoproteins. Next, the lipid composition of the different pools of lipoproteins obtained by FPLC separation was analyzed. HDL-cholesterol was increased by on average 25% for all tested conditions in HSL-null mice: ND and HFD;
re-fed and fasted (P < 0.01 or less) (Table 4A and Fig. 3A ). In addition, FPLC analysis revealed an increased of VLDL-cholesterol in fed HSL-null mice on ND and on HFD and in fasted HSL-null mice on HFD (P < 0.01 or less) (Table 4A and Fig. 3A) . In re-fed HSL-null mice on ND and on HFD, increased VLDL-cholesterol was associated with a similar increase in triglyceride content, i.e. an average increase of 2.2-and 2.8-fold, respectively (P < 0.01 or less), suggesting that re-fed HSL-null mice exhibit an expansion of their VLDL pool.
However, the VLDL-cholesterol of fasted HSL-null mice on HFD was doubled, whereas the triglycerides were halved (P < 0.01 or less), indicating that the VLDL composition of fasted HSL-null mice on HFD is altered (Tables 4A and B , Fig. 3A and B). No changes were observed for IDL/LDL-cholesterol under any of the tested conditions (Table 4A and Fig. 3A ).
However, as observed for the VLDL, re-fed HSL-null mice on ND and on HFD had on average a 2-fold increase of their IDL/LDL-triglycerides (P < 0.05 or less) while fasted HSLnull mice on HFD presented a 0.6-fold decrease of their IDL/LDL-triglycerides (P < 0 05) (Table 4B and Fig. 3B ). HSL-null mice overexpress ABCA1 in the liver. The increase of plasma total cholesterol, HDL-cholesterol, non-HDL-cholesterol and hepatic cholesterol, as well as the altered expression of hepatic HMG-CoA reductase observed in HSL-null mice, are reminiscent of the phenotype described for mice overexpressing ABCA1 in the liver (1, 19) . Indeed, an elevation of hepatic ABCA1 mRNA levels, in fed HSL-null mice on HFD, was observed in the microarray analysis (2-fold and 1.8-fold increase) ( Table 2 ). Although this finding was not reproduced by RT-PCR on fed mice, hepatic ABCA1 mRNA expression was shown to be increased by RT-PCR in fasted HSL-null mice on ND and on HFD by 1.4-and 1.5-fold, respectively (P < 0.05 and P < 0.01) (Fig. 5A ). In addition, hepatic ABCA1 protein levels were investigated by western blot analysis (Fig. 5B) . ABCA1 appeared as cleaving products around 100 kDa rather than as the expected full-length 220 kDa protein. The double band was quantified using the ImageJ software and ABCA1 protein levels were found to be elevated in HSL-null mice versus wildtype regardless of the dietary regimen and of the nutritional state (3.3-fold increase for fed mice on ND; 15-fold increase for fed mice on HFD; 1.8-fold increase for fasted mice on ND; 2.4-fold increase for fasted mice on HFD) (Fig. 5B) . Next, the mRNA levels of other transporters and receptors involved in hepatic cholesterol homeostasis were analyzed. No differences were observed for any of the groups in the expression of ATP-binding cassette transporter G1 (Abcg1), the transporter of cholesterol to lipidated apolipoprotein A-I (data not shown) (46). The LDL receptor mRNA levels were decreased in fed and fasted HSL-null mice on HFD by 0.7-and 0.4-fold, respectively (P < 0.05 and P < 0.01) and trended towards a reduction in fed and fasted HSL-null mice on ND (P > 0.05) (Fig. 6A ). Scavenger receptor class B type I (SR-BI) mRNA levels were downregulated 0.7-fold in fed HSL-null mice on ND (P < 0.05) and up-regulated 1.6-fold in fasted HSL-null mice on HFD (P < 0.01) (Fig. 6B) . Low density lipoprotein receptor-related protein 1 (LRP1) mRNA levels were increased by 1.5-fold in fasted HSL-null mice on HFD (P = 0.052) (Fig. 6C) .
HSL-null mice
Modification of hepatic triacylglycerol unsaturated fatty acid profile in 16 hours fasted
HSL-null mice. Since it has been reported that unsaturated fatty acids suppress the expression of ABCA1, we investigated the hepatic triglycerides fatty acid profile of HSL-null mice. Hepatic total triglycerides were quantified in fed and fasted mice on ND and on HFD but no differences were observed between HSL-null and wildtype mice (data not shown).
However unsaturated fatty acid composition of hepatic triglycerides was modified in fasted HSL-null mice on ND and HFD, i.e. palmitoleic (16:1), linoleic (18:2) and gamma-linolenic Table S1 ).We also measured the expression level of hepatic stearoyl CoA desaturase 1 (Scd1), a key enzyme in the biosynthesis of hepatic monounsaturated fatty acids (20). Scd1 levels were almost doubled in fasted HSLnull mice on ND and on HFD (P = 0.051 and P < 0.05, respectively) (Fig. 6D) .
Similar apoA-I-mediated cholesterol efflux from HSL-null mouse hepatocytes and wildtype mouse hepatocytes. The next step was to assess whether the upregulation of hepatic ABCA1
at the mRNA and protein levels was accompanied by increased ABCA1 action in HSL-null mouse hepatocytes. One way to achieve this is to measure apoA-I-specific cholesterol efflux since ABCA1 functions by adding cholesterol and phospholipids to lipid poor ApoA-1 to generate nascent HDL (24, 41). Thus, hepatocytes were isolated by collagenase digestion from mice of the four experimental groups. However, hepatocytes isolated from mice fed a HFD for an extensive period of time (approximately 10 months) revealed very few surviving cells when analyzed by trypan blue exclusion both in wildtype and HSL-null mice (two unsuccessful attempts were made per genotype). Consequently, the apoA-I mediated cholesterol efflux could only be analyzed in mice fed the ND. Not only were hepatocytes from HDF-fed mice much more fragile than hepatocytes from mice fed a ND, but we also observed that hepatocytes from HSL-null mice were less robust than hepatocytes from wildtype mice, as indicated by a much lower number of surviving cells (data not shown). The increase in efflux of labelled cholesterol induced by apoA-I tended to be similar for wildtype and HSL-null mouse hepatocytes (i.e. 1.3-fold and 1.5-fold, respectively and P = 0. 1) (Fig.   7 ). Moreover, labelled cholesterol efflux to apoA-I was similar in HSL-null mouse hepatocytes and wildtype mouse hepatocytes (Fig. 7) .
DISCUSSION
The present study demonstrates that disruption of the HSL gene in the mouse results in disturbed cholesterol homeostasis. Plasma cholesterol levels were elevated in HSL-null mice, due to cholesterol enrichment of HDL and VLDL. Moreover, hepatic esterified cholesterol was increased and HMG-CoA reductase, together with seven other genes coding for enzymes catalyzing successive steps in de novo synthesis of cholesterol, were down-regulated in HSLnull mice. An overview of the various cholesterol fluxes that were modified in the liver of HSL-null mice is depicted in Fig. 8 .
Elevation of plasma levels of total cholesterol and HDL-cholesterol has previously been described in the fed and 16-hour fasted state of another strain of HSL-null mice on a normal chow diet (15) . However, the effect of challenging the mice with a HFD for an extensive period of time has not been investigated previously. Here we confirm the previous findings with regard to ND. Furthermore, we demonstrate that total and HDL-cholesterol are elevated also in re-fed HSL-null mice on ND (over-night fasting for 12 hours followed by 2 hours of free access to food) as well as in re-fed and 16 hours fasted HSL-null mice that had been on a HFD for about 6 months. The increase in HDL-cholesterol in the fasted state could be due to the increased lipoprotein lipase (LPL) activity reported in muscle and white adipose tissue of fasted HSL-null mice (15) , since a positive correlation between LPL activity and HDLcholesterol concentrations has been reported (23). However, it could not explain the elevation of HDL-cholesterol in the fed state, since LPL activity was shown to be reduced in white adipose tissue and unchanged in skeletal muscle of fed HSL-null mice (15) . Moreover, it has been reported that under normal chow feeding, only mice expressing the simian cholesteryl ester transfer protein (CETP) transgene had their HDL-cholesterol levels significantly affected by LPL activity, whereas when mice were fed a high fat/ high carbohydrate diet, LPL activity was correlated to HDL-cholesterol levels regardless of the expression of CETP (8). Thus, several mechanisms are likely to contribute to the elevation of HDL-cholesterol in HSL-null mice. Among these are mechanisms relating to the increased hepatic cholesterol ester content and the increased expression of hepatic ABCA1, as discussed further below.
It has been demonstrated that total hepatic cholesterol levels are elevated in HSL-null mice under ND condition and following a HFD regimen for 15 weeks (17) . Here, we confirm this observation in another strain of HSL-null mice and extend it to show that the elevation is accounted for by esterified cholesterol, whereas the levels of free cholesterol are unchanged. 29). Additionally, the composition of NEFA released after in vitro lipolysis from white adipose tissue was altered in another strain of HSL-null mice fed a ND (14) . Overall, decreased delivery of unsaturated fatty acids to the liver, as a result of lack of HSL action in white adipose tissue, might be at least one mechanism whereby hepatic ABCA1 expression is increased in HSL-null mice.
ABCA1-dependent cholesterol efflux from primary hepatocytes was measured to evaluate the consequences of the upregulation of hepatic ABCA1 expression in HSL-null mice. The ex vivo study showed no differences in ABCA1-mediated cholesterol efflux from HSL-null mouse hepatocytes compared to wildtype mouse hepatocytes. Thus, the increased expression of hepatic ABCA1 in HSL-null mice had no major effect on cholesterol efflux.
This indicates that hepatic accumulation of cholesteryl esters due to lack of action of hepatic HSL is the predominant mechanism behind the disturbed cholesterol metabolism displayed by the HSL-null mice. Further support for this notion comes from a very recent study that was published during the preparation of this manuscript (33). Nonetheless, the possibility remains that the situation is different in the HFD-fed mice, an experimental condition that could not be evaluated, due to the poor survival of hepatocytes from long-term HFD-fed mice.
In addition to HDL-cholesterol, VLDL-cholesterol was also increased in re-fed HSLnull mice on ND and on HFD as well as in fasted HSL-null mice on HFD. In re-fed HSL-null mice, plasma NEFA were increased, providing the liver with more substrate for triglycerides synthesis. Thus, the increase in VLDL-cholesterol was associated with a similar elevation of VLDL-triglycerides, indicating that the VLDL pool was increased. In fasted mice on HFD, the lack of expression of HSL in the white adipose tissue was reflected in a reduction of plasma NEFA by 45%, associated with a lowering in VLDL triglycerides by 55% although The relevance of the results of the present study for human physiology is difficult to evaluate for several reasons. First, there are major differences in lipid and lipoprotein metabolism between mice and humans. In particular, high HDL/LDL ratios and lack of CETP are major contributors to the low susceptibility to atherosclerosis of mice compared to humans. Second, the type of gene inactivation employed in this study, i.e. total whole body inactivation from early embryogenesis and onwards, is extreme and may induce compensatory changes that obscure the interpretation of the phenotype. A human counterpart to the experimental model employed in this study does not exist as total HSL deficiency has not been described in humans. Noteworthy, however, low HSL activity has been reported in familial combined hyperlipidemia (FCHL) (30) and a substitution (C-60G) in the HSL promoter that may have a role in determining serum cholesterol levels in FCHL families has been described (57). In addition, an HSL amino acid polymorphism that is correlated to mildly elevated levels of serum total cholesterol in Japanese subjects has been reported (34).
Future studies, including targeted and moderate knockdown experiments in adult mice as well as studies in humans addressing the lipoprotein composition in relation to HSL activity will have to be performed in order to establish the relevance of the current findings for cholesterol homeostasis in humans.
In conclusion, our results show that plasma cholesterol is elevated in HSL-null mice due to cholesterol enrichment of VLDL and HDL. It is likely that several mechanisms contribute to the altered cholesterol homeostasis in HSL-null mice, of which we have described two, i.e. increased ABCA1 expression and hepatic accumulation of cholesteryl esters due to lack of action of hepatic HSL, where the latter appears to be more important than the former. Differences between the two genotypes were analyzed using non-parametric Mann-Whitney U-test and n = 5.
FC, free cholesterol; EC, esterified cholesterol; TC, total cholesterol. Thin arrows indicate fluxes that were down-regulated in HSL-null mice versus wildtype mice; thick arrows indicate fluxes that were up-regulated. The dashed arrow designates a flux that needs further study. 
